Al-Madina Pharmaceuticals Limited announcements
60 Dhaka Stock Exchange announcements for Al-Madina Pharmaceuticals Limited (AMPL) since 2023: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (12).
- The company has informed that they have started the export of pharma products to Hejaz Ltd. They have already received t
The company has informed that they have started the export of pharma products to Hejaz Ltd. They have already received the Expo Form for USD 64,851.63 from Al-Arafah Islami Bank PLC. as per Sales Contract. Sales Contract value is USD 1,31,875.
- Trading of the shares of the company will resume on 03.11.2024.
Trading of the shares of the company will resume on 03.11.2024.
- Trading of the shares of the company will remain suspended on record date i.e., 31.10.2024.
Trading of the shares of the company will remain suspended on record date i.e., 31.10.2024.
- Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 29.10.2024 to 30.10.2024 and trading of the shares of the company will remain suspended on record date i.e., 31.10.2024.
- The company has informed that they will be starting the export of Pharma products on 1.11.2024 to Hejaz Ltd. They have a
The company has informed that they will be starting the export of Pharma products on 1.11.2024 to Hejaz Ltd. They have already received in advanced TT swift USD 37,294.50 and also taken order USD 1,31,875 from Hejaz Ltd., Afghanistan. Now, they are producing the export product as per Sales Contract.
- The Board of Directors has recommended 12\% Cash Dividend for General Shareholders (excluding Sponsors and or Directors)
The Board of Directors has recommended 12\% Cash Dividend for General Shareholders (excluding Sponsors and or Directors) for the year ended June 30, 2024. The Sponsors and Directors hold 1,42,50,000 shares out of total 20,400,000 shares of the company and Cash Dividend payable to the General Shareholders is Tk. 7,380,000.00. Date of AGM: 26.12.2024, Time: 11:00 AM, Venue: Digital Platform through the link https://almadinapharma.bdvirtualagm.com. Record Date: 31.10.2024. (cont.1)
- (Cont. news of AMPL): The Company has reported EPS of Tk. 0.87 (Basic/Weighted Average), EPS of Tk. 0.87 (Diluted), NAV
(Cont. news of AMPL): The Company has reported EPS of Tk. 0.87 (Basic/Weighted Average), EPS of Tk. 0.87 (Diluted), NAV per share of Tk. 20.39 (with revaluation), NAV per share of Tk. 13.58 (without revaluation) and NOCFPS of Tk. 2.50 for the year ended June 30, 2024 as against Tk. 1.57 (Basic/Weighted Average), Tk. 1.23 (Diluted), Tk. 19.82 (with revaluation), Tk. 13.00 (without revaluation) and NOCFPS of Tk. (1.64) respectively for the year ended June 30, 2023. (end)
The first part of this announcement is missing from the archive. - There will be no price limit on the trading of the shares of the Company today (14.10.2024) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (14.10.2024) following its corporate declaration.
- As per Regulation 17(1) of the Dhaka Stock Exchange (Listing of Small Capital Companies) Regulations, 2019, the Company
As per Regulation 17(1) of the Dhaka Stock Exchange (Listing of Small Capital Companies) Regulations, 2019, the Company has informed that a meeting of the Board of Directors will be held on October 10, 2024 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- The company has informed that it is trying to develop the sale of Pharma products. At this moment, it has completed agre
The company has informed that it is trying to develop the sale of Pharma products. At this moment, it has completed agreement with Essential Drugs Company Limited (EDCL) for toll manufacturing as per requirements of EDCL. The company is waiting for receiving the manufacturing order from EDCL.
- Alpha Credit Rating Limited has assigned Surveillance rating of the Company as \"A-\" in the long term and \"ST-2\" in t
Alpha Credit Rating Limited has assigned Surveillance rating of the Company as \"A-\" in the long term and \"ST-2\" in the short term along with Stable outlook based on audited financial statements as on June 30, 2023 and relevant qualitative information till January 28, 2024.
- The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shar
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.